Santen Pharmaceutical Co., Ltd. (TYO:4536)
Japan · Delayed Price · Currency is JPY 1,861.50
-27.00 (-1.43%)
Jun 19, 2026, 2:05 PM JST
Santen Pharmaceutical Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Santen Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥2,259. The average 1-year stock price forecast is 21.35% higher than the current stock price, while the lowest is ¥1,800 (-3.30%) and the highest is ¥2,800 (+50.42%).
Price Target: ¥2,259 (+21.35%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Santen Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Financial Forecast
Revenue This Year
304.20B
from 291.62B
Increased by 4.31%
Revenue Next Year
313.63B
from 304.20B
Increased by 3.10%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is JPY.
Revenue Forecast
| Revenue | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 311.7B | ||
| Avg | 304.2B | ||
| Low | 292.4B |
Revenue Growth
| Revenue Growth | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | 6.9% | ||
| Avg | 4.3% | ||
| Low | 0.3% |
EPS Forecast
| EPS | 2027 | 2028 | 2029 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |
EPS Growth
| EPS Growth | 2028 | 2029 |
|---|---|---|
| High | - | |
| Avg | - | |
| Low | - |